Attorneys:
In a burst of IPO activity, Ropes & Gray represented, among other clients in other offerings, clients in two life sciences IPOs with an aggregate value of $540 million:
- The underwriters in Bicara Therapeutics’ $315 million initial public offering, which priced on Sept. 12. The deal team included capital markets partner Tom Danielski and counsel Ray Grant. The transaction is the third-largest IPO of the year, according to BioPharma Dive data, and was announced in a Sept.12 press release.
- Zenas BioPharma in its $225 million initial public offering, which priced on Sept. 12 and was announced in a press release. The deal team included capital markets partner Tom Danielski and counsel Nicholas Roper, executive compensation & employee benefits partner Ellen Sueda,health care partner Eve Brunts, and life sciences regulatory & compliance partner Kellie Combs.
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.